fluconazole
Generic: fluconazole
Labeler: direct rxDrug Facts
Product Profile
Brand Name
fluconazole
Generic Name
fluconazole
Labeler
direct rx
Dosage Form
TABLET
Routes
Active Ingredients
fluconazole 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
61919-493
Product ID
61919-493_0e88c9e2-8dbd-917c-e063-6294a90a6ec9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208963
Listing Expiration
2026-12-31
Marketing Start
2019-04-08
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
61919493
Hyphenated Format
61919-493
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fluconazole (source: ndc)
Generic Name
fluconazole (source: ndc)
Application Number
ANDA208963 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 3 TABLET in 1 BOTTLE (61919-493-03)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0e88c9e2-8dbd-917c-e063-6294a90a6ec9", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "unii": ["8VZV102JFY"], "rxcui": ["197700"], "spl_set_id": ["69f199fa-bb92-4837-8b12-427a1c71f622"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Direct Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "3 TABLET in 1 BOTTLE (61919-493-03)", "package_ndc": "61919-493-03", "marketing_start_date": "20190408"}], "brand_name": "Fluconazole", "product_id": "61919-493_0e88c9e2-8dbd-917c-e063-6294a90a6ec9", "dosage_form": "TABLET", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "61919-493", "generic_name": "Fluconazole", "labeler_name": "Direct Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluconazole", "active_ingredients": [{"name": "FLUCONAZOLE", "strength": "200 mg/1"}], "application_number": "ANDA208963", "marketing_category": "ANDA", "marketing_start_date": "20190408", "listing_expiration_date": "20261231"}